Why in the World Is Novavax Stock Up 4,000%?

Why in the World Is Novavax Stock Up 4,000%?

It was trading at $4 a share, and its market capitalization was barely over $100 million. The biotech had no profits and no FDA-approved drugs. This tiny company had arguably the best flu vaccine in the world, NanoFlu.